Literature DB >> 890709

Cardiovascular and antiarrhythmic effects of aprindine (AC1802) during partial occlusion of a coronary artery in the pig.

P D Verdouw, W J Remme, P G Hugenholtz.   

Abstract

The effect of intravenously administered aprindine (AC1802) as a prophylactic agent against ventricular arrhythmias was studied in pigs. During the first 30 min of ischaemia 5 of the 22 untreated animals died because of ventricular fibrillation against 1 of the 23 animals pretreated with aprindine (P=0.09). Ventricular tachycardias were observed in 10 untreated animals and in none of the aprindine group (P=0.0002). The incidence of other arrhythmias was significantly less in the aprindine group compared with the untreated group (P less than 0.02).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 890709     DOI: 10.1093/cvr/11.4.317

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  4 in total

1.  Ventricular arrhythmias and mortality associated with isoflurane and sevoflurane in a porcine model of myocardial infarction.

Authors:  Marta Regueiro-Purriños; Felipe Fernández-Vázquez; Armando Perez de Prado; Jose R Altónaga; Carlos Cuellas-Ramón; Jose M Ajenjo-Silverio; Asuncion Orden; Jose M Gonzalo-Orden
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-01       Impact factor: 1.232

2.  Haemodynamic effects of intravenous cibenzoline in patients with coronary heart disease.

Authors:  M van den Brand; P Serruys; Y de Roon; M F Aymard; A Dufour
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Myocardial substrate utilization and hemodynamics following repeated coronary flow reduction in pigs.

Authors:  P D Verdouw; W J Remme; J W de Jong; W A Breeman
Journal:  Basic Res Cardiol       Date:  1979 Sep-Oct       Impact factor: 17.165

4.  A modified regionally ischemic porcine heart preparation with eligible residual blood flows.

Authors:  H H Klein; K Nebendahl; S Lindert; J Schrader; H Kreuzer
Journal:  Basic Res Cardiol       Date:  1986 Jul-Aug       Impact factor: 17.165

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.